NPCE earnings date and last-quarter result: next report 2026-08-11, last quarter beat, P/E -22.37. Updated 2026-07-23.
NeuroPace (NPCE) Research Hub
NeuroPace (NPCE) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 12.99 USD (+0.62%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -22.37, market cap 0.51B. This hub links to the full technical, earnings and options research available for NPCE.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 12.99 USD (+0.62%) |
| 52-week range | 12.13 USD – 18.23 USD |
| Trend regime | Range |
| 14-day RSI | 53.6 (Neutral) |
| Trailing P/E | -22.37 |
| Market cap | 0.51B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for NPCE
Covered Call on NPCE: how it works, illustrative setup around the real 12.99 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NPCE: how it works, illustrative setup around the real 12.99 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NPCE: how it works, illustrative setup around the real 12.99 USD price, max profit/loss, breakeven and when to use it. Educational.
NPCE technical analysis: range, last 12.99 USD, RSI 53.6, 52w range 12.13 USD–18.23 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NPCE in?
NeuroPace (NPCE) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is NPCE in an uptrend or downtrend?
As of 2026-10-26, NPCE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NPCE's trailing P/E ratio?
NPCE's trailing P/E is -22.37, with a market cap of 0.51B. See the earnings research page for full valuation detail.
When does NPCE next report earnings?
NPCE is next scheduled to report earnings on 2026-08-11.